Inhalerx Ltd (IRX) — Strategic Asset Allocation Index
Inhalerx Ltd (IRX) has a Strategic Asset Allocation Index of 0.0% as of December 2022. Strategic assets (PP&E of AU$0.00 plus long-term investments of AU$-) total AU$0.00, measured against net assets of AU$1.93 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See IRX net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Inhalerx Ltd Strategic Asset Allocation Index (2016–2022)
This chart shows how Inhalerx Ltd's Strategic Asset Allocation Index has evolved across 6 annual periods from 2016 to 2022. As of December 2022, the index stands at 0.0%, representing strategic assets of AU$0.00 against net assets of AU$1.93 Million AUD. For live market cap and overall valuation, see market cap of Inhalerx Ltd.
Annual Strategic Asset Allocation Index for Inhalerx Ltd (2016–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Inhalerx Ltd from 2016 to 2022, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Inhalerx Ltd (IRX) net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (AUD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 0.0% | AU$0.00 | AU$0.00 | AU$- | AU$1.90 Million | ▼ -0.4 pp |
| 2021 | 0.4% | AU$9.71K | AU$9.71K | AU$- | AU$2.68 Million | ▲ +0.4 pp |
| 2019 | 0.0% | AU$0.00 | AU$0.00 | AU$- | AU$340.08K | ▼ -3.6 pp |
| 2018 | 3.6% | AU$96.11K | AU$96.11K | AU$- | AU$2.68 Million | ▲ +2.4 pp |
| 2017 | 1.2% | AU$54.43K | AU$54.43K | AU$- | AU$4.51 Million | ▲ +0.8 pp |
| 2016 | 0.4% | AU$27.00K | AU$27.00K | AU$- | AU$7.33 Million | — |